Newborn screening for lysosomal storage diseases: an ethical and policy analysis.

Newborn screening for lysosomal storage diseases: an ethical and policy analysis.

Item
http://www.wikidata.org/entity/Q37970587
The evolution of blood-spot newborn screeningThe hidden Niemann-Pick type C patient: clinical niches for a rare inherited metabolic disease.Stakeholder attitudes towards the role and application of informed consent for newborn bloodspot screening: a study protocolNewborn screening for pompe disease? a qualitative study exploring professional viewsPompe disease: literature review and case seriesIdentification of infants at risk for developing Fabry, Pompe, or mucopolysaccharidosis-I from newborn blood spots by tandem mass spectrometry.Biobank participant support of newborn screening for disorders with variable treatment and intervention options.Universal screening for inherited metabolic diseases in the neonate (and the fetus).Inborn errors of metabolism and expanded newborn screening: review and update.Psychosine, a marker of Krabbe phenotype and treatment effect.Newborn Screening for Lysosomal Storage Disorders: Views of Genetic Healthcare Providers.International differences in the evaluation of conditions for newborn bloodspot screening: a review of scientific literature and policy documents.Newborn screening for Fabry disease in the north-west of Spain.Medicine. Newborn screening: gaps in the evidence.Benefits and burdens of newborn screening: public understanding and decision-making
P2860

Newborn screening for lysosomal storage diseases: an ethical and policy analysis.

Item
http://www.wikidata.org/entity/Q37970587
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Newborn screening for lysosomal storage diseases: an ethical and policy analysis.
@en
Newborn screening for lysosomal storage diseases: an ethical and policy analysis.
@nl
type
label
Newborn screening for lysosomal storage diseases: an ethical and policy analysis.
@en
Newborn screening for lysosomal storage diseases: an ethical and policy analysis.
@nl
prefLabel
Newborn screening for lysosomal storage diseases: an ethical and policy analysis.
@en
Newborn screening for lysosomal storage diseases: an ethical and policy analysis.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Newborn screening for lysosomal storage diseases: an ethical and policy analysis.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698
P921